MedPath

Ventricular Tachycardia in Ischemic Cardiomyopathy; a Combined Endo-Epicardial Ablation Within the First procedure Versus a Stepwise Approach a randomized controlled trial

Recruiting
Conditions
scar related ventricular tachycardiadutch: ventrikel tachycardie
Registration Number
NL-OMON22465
Lead Sponsor
ErasmusMC
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
Not specified
Target Recruitment
125
Inclusion Criteria

1. clinical indication for ablation of a monomorphic ventricular tachycardia referred to one of the participating ablation centers

Exclusion Criteria

1. current unstable angina as defined by current european guidelines

2. AMI < 30 days or in case of incessant VT < 14 days

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The main study endpoint is the difference in recurrences of ventricular tachycardia on follow-up - clinical or on ICD interrogation - between the two ablation groups
Secondary Outcome Measures
NameTimeMethod
The secondary endpoints are procedure success and safety
© Copyright 2025. All Rights Reserved by MedPath